Taxpas: Epidemiological and Survival Data in Breast Cancer Patients Treated with a Docetaxel-Based Chemotherapy Regimen in South Africa

Table 1

Number of patients according to stage.

	Overall 𝑛 (%)	Early stage breast cancer 𝑛 (%)	Metastatic breast cancer 𝑛 (%)	Stage unknown 𝑛 (%)
Total cohort at baseline	1632/1632 (100%)	1394/1632 (85%)	162/1632 (10%)	76/1632 (5%)
Total cohort at 1-year followup	1632/1632 (100%)	989/1632 (61%)	560/1632 (34%)	83/1632 (5%)
TNBC	232/1632 (14%)	149/232 (64%)	66/232 (28%)	17/232 (7%)
N-TNBC	1400/1632 (86%)	835/1400 (60%)	494/1400 (35%)	71/1400 (5%)
Age ≤50 years	757/1632 (46%)	520/757 (69%)	193/757 (25%)	44/757 (6%)
Age >50 years	875/1632 (53%)	464/875 (53%)	367/875 (42%)	44/875 (5%)